Qardio
- Industry
- Health Technology
- Founded Year
- 2012
- Headquarters
- San Francisco, California, United States
- Employee Count
- 18
Key People
- Mike Alvarez - Chief Executive Officer
- Rosario Iannella - Founder and Chief Technology Officer
- Daniel Gasparini - Chief Commercial Officer
- Sandeep Yadav - Chief Financial Officer
- Dr. Asif Ali - Chief Medical Officer
- Andreia Esteves - VP of Application Development
- Tony Meyers - VP of North American Sales
- Mike Ketcham - VP Marketing
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical technology and business development.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: Qardio addresses a significant need for remote health monitoring solutions, especially for chronic heart conditions.
With the rising prevalence of chronic heart diseases, Qardio's solutions offer timely and essential monitoring capabilities.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for remote health monitoring devices is competitive, with several established players.
While Qardio's products are innovative, the presence of multiple competitors necessitates strong differentiation and marketing strategies.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of Qardio's devices involves manageable technical challenges with established solutions.
Leveraging existing technologies and expertise, Qardio can effectively manage the technical development of its products.
- Patent
-
Aspect: Strong
Summary: Qardio holds patents that provide a competitive edge in the market.
Holding strong patents allows Qardio to protect its innovations and maintain a competitive advantage.
- Financing
-
Aspect: Medium
Summary: Qardio has secured moderate funding to support its operations and growth.
While current funding supports existing operations, further investment could enhance product development and market penetration.
- Regulatory
-
Aspect: 510k/PMA
Summary: Qardio's products have received necessary regulatory clearances, including FDA 510(k) approvals.
Achieving regulatory clearances demonstrates product safety and efficacy, essential for market acceptance.
Opportunity Rollup
- Odds of Success
- 4.15
- Peak Market Share
- 5.4
- Segment CAGR
- 4.4%
- Market Segment
- Cardiovascular Devices
- Market Sub Segment
- Remote Health Monitoring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.27 |
| 2 | 0.81 |
| 3 | 1.89 |
| 4 | 3.78 |
| 5 | 5.40 |
Key Takeaway
Qardio is well-positioned in the growing remote health monitoring market, leveraging a strong team and innovative products to address critical healthcare needs.